Judd, Shirley 
ORCID: 0000-0001-9792-0046, Khedr, Milad, Milan, Anna M ORCID: 0000-0002-0452-2338, Davison, Andrew S ORCID: 0000-0001-5501-4475, Hughes, Andrew T, Needham, Alexander, Psarelli, Eftychia E ORCID: 0000-0002-3102-0288, Shenkin, Alan and Ranganath, Lakshiminaryan R
(2020)
The nutritional status of people with alkaptonuria: An exploratory analysis suggests a protein/energy dilemma.
JIMD reports, 53 (1).
pp. 45-60.
|
Text
The nutritional status of people with alkaptonuria An exploratory analysis suggests a proteinenergy dilemma.pdf - Published version Download (2MB) | Preview |
Abstract
<h4>Background</h4>Alkaptonuria (AKU) is a disorder of tyrosine/protein metabolism leading to accumulation of homogentisic acid. Clinical management historically recommended reducing dietary protein intake, especially in childhood, which has since been discredited in the literature. For the first time, analysis of baseline cross-sectional nutritional surveillance data from a large cohort of AKU patients is presented, which has clinical implications in all aspects of treatment planning.<h4>Method</h4>Seventy-four patients (mean 55 years) admitted to the National Alkaptonuria Centre (NAC), underwent a global nutritional assessment, which included objective anthropometry, bioimpedance measures, habitual nutritional intake using a 7-day food diary and key nutritional biomarkers, including 24 hours urinary nitrogen, serum albumin, total protein and total 25-hydroxy vitamin D. All data was compared with cohort norms or recommended nutrient intakes for health (RNI). The potential beneficial impact of protein and anti-inflammatory nutrients such as vitamin C, selenium, and zinc were statistically interrogated against the AKU severity score index (AKUSSI)-a validated measure of disease progression stratified by age.<h4>Results</h4>Fifty percent of AKU patients reported some level of protein restriction at some point in their lives. In comparison with national data sets, AKU patients present with significantly lower than predicted mid-upper arm circumference, grip strength, BMI, total energy and protein intake, and higher than predicted percentage body fat. They therefore meet the ESPEN criteria as "clinically undernourished." Severity fluctuates over the life course. No statistical association is identified between protein intake, expressed as %RNI or g/kg, or anti-inflammatory nutrients, including vitamin C as a high dose supplement on the severity of the disease, when correlated against the validated AKUSSI score.<h4>Conclusion</h4>AKU patients are at risk of protein depletion associated with a "perfect storm" of risk factors: historical, poorly evidenced recommendations to reduce total protein intake; limited mobility as the condition progresses, compromising muscle integrity; frequent hospital admissions for major surgery associated with multiple joint replacements, creating pinch points of high metabolic demand and the potential impact of the disease itself. As this is the first time this risk has been identified, the authors consider the dietetic implications of nitisinone treatment, which requires dietary protein control to manage the acquired tyrosinaemia. The lack of statistically significant evidence to support dietary manipulation of any kind to impede disease progression in AKU is demonstrated.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | alkaptonuria, global nutritional assessment, protein energy deficit |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 01 Jun 2020 10:11 |
| Last Modified: | 18 Jan 2023 23:50 |
| DOI: | 10.1002/jmd2.12084 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3089173 |
Dimensions
Dimensions
